{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:24:44Z","timestamp":1791217484013,"version":"4.1.0"},"reference-count":269,"publisher":"Elsevier BV","issue":"13-14","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.addr.2013.09.002","type":"journal-article","created":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T07:45:18Z","timestamp":1379490318000},"page":"1828-1851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing \u201cGenerally Recognized As Safe\u201d (GRAS) nanopharmaceuticals: A review"],"prefix":"10.1016","volume":"65","author":[{"given":"Alejandro","family":"Sosnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2013.09.002_bb0005","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/346362a0","article-title":"Structural model of ATP-binding protein associated with cystic fibrosis, multidrug resistance and bacterial transport","volume":"346","author":"Hyde","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.addr.2013.09.002_bb0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.addr.2013.09.002_bb0015","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nature05630","article-title":"Multiple molecular mechanisms for multidrug resistance transporters","volume":"446","author":"Higgins","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.addr.2013.09.002_bb0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0076-6879(05)00024-8","article-title":"The genetics of ATP-binding cassette transporters","volume":"400","author":"Dean","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.addr.2013.09.002_bb0025","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/BF02482982","article-title":"P-glycoprotein-expressing tumor cells are resistant to anticancer drugs in human gastrointestinal cancer","volume":"29","author":"Hotta","year":"1999","journal-title":"Surg. Today"},{"key":"10.1016\/j.addr.2013.09.002_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview","volume":"55","author":"Schinkel","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2013.09.002_bb0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/jac\/dkl474","article-title":"Modulation of human BCRP (ABCG2) activity by anti-HIV drugs","volume":"59","author":"Weiss","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2013.09.002_bb0040","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-2275(20)31588-1","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"42","author":"Dean","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0045","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.addr.2012.09.042","article-title":"Intestinal drug transporters: an overview","volume":"65","author":"Estudante","year":"2013","journal-title":"Adv Drug Deliv Rev."},{"key":"10.1016\/j.addr.2013.09.002_bb0050","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/glia.20725","article-title":"Regulation of ABC membrane transporters in glial cells: relevance to the pharmacotherapy of brain HIV-1 infection","volume":"56","author":"Ronaldson","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.addr.2013.09.002_bb0055","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/pr.58.2.3","article-title":"Multidrug resistance-associated proteins: expression and function in the central nervous system","volume":"58","author":"Dallas","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.addr.2013.09.002_bb0060","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1007\/s11095-009-9930-2","article-title":"Inner blood-retinal barrier transporters: role of retinal drug delivery","volume":"26","author":"Hosoya","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0065","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1517\/17425255.2010.486401","article-title":"The role of blood\u2013ocular barrier transporters in retinal drug disposition: an overview","volume":"6","author":"Tomi","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.addr.2013.09.002_bb0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tips.2010.11.007","article-title":"Emerging role for drug transporters at the blood\u2013testis barrier","volume":"32","author":"Mruk","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.addr.2013.09.002_bb0075","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1476-5381.2009.00336.x","article-title":"Drug transporters in the human blood-placental barrier","volume":"158","author":"V\u00e4h\u00e4kangas","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.addr.2013.09.002_bb0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1124\/jpet.111.186916","article-title":"Expression of ATP-Binding cassette membrane transporters in rodent and human sertoli cells: relevance to the permeability of antiretroviral therapy at the blood\u2013testis barrier","volume":"340","author":"Robillard","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2013.09.002_bb0085","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2174\/138161210790112683","article-title":"Pharmacogenetics of drug transporters","volume":"16","author":"Franke","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.addr.2013.09.002_bb0090","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2789","article-title":"ABC transporters in cancer: more than just drug efflux pumps","volume":"10","author":"Fletcher","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.addr.2013.09.002_bb0095","first-page":"399","article-title":"Why chemotherapy can fail?","volume":"13","author":"Kr\u00f3l","year":"2010","journal-title":"Pol. J. Vet. Sci."},{"key":"10.1016\/j.addr.2013.09.002_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2008.11.003","article-title":"ABCG2: a perspective","volume":"61","author":"Robey","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2013.09.002_bb0105","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jhep.2005.11.036","article-title":"Cellular and virological mechanisms of HBV drug resistance","volume":"44","author":"Locarnini","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.addr.2013.09.002_bb0110","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s11095-010-0112-z","article-title":"Drug delivery systems and liver targeting for the improved pharmacotherapy of the hepatitis B virus (HBV)","volume":"27","author":"Cuestas","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI1269","article-title":"The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors","volume":"101","author":"Kim","year":"1998","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.addr.2013.09.002_bb0120","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/12487","article-title":"MRP4: a previously unidentified factor in resistance to nucleoside-based antiviral drugs","volume":"5","author":"Schuetz","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2013.09.002_bb0125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1937-6448(10)80005-X","article-title":"Impact of ATP-binding cassette transporters on human immunodeficiency virus therapy","volume":"280","author":"Weiss","year":"2010","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.addr.2013.09.002_bb0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0169-409X(99)00026-5","article-title":"Involvement of multiple transporters in the oral absorption of nucleoside analogues","volume":"39","author":"Balimane","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2013.09.002_bb0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0169-409X(99)00022-8","article-title":"P-glycoprotein, secretory transport, and other barriers to the oral delivery of anti-HIV drugs","volume":"39","author":"Aungst","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2013.09.002_bb0140","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/gut.52.12.1788","article-title":"ABC of oral bioavailability: transporters as gatekeepers in the gut","volume":"52","author":"Dietrich","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.addr.2013.09.002_bb0145","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1081\/CNV-58823","article-title":"Modulation of oral drug bioavailability: from preclinical mechanism to therapeutic application","volume":"23","author":"Kuppens","year":"2005","journal-title":"Cancer Invest."},{"key":"10.1016\/j.addr.2013.09.002_bb0150","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/01.aids.0000162333.35686.4c","article-title":"Renal tubular transporters and antiviral drugs: an update","volume":"19","author":"Izzedine","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.addr.2013.09.002_bb0155","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1124\/dmd.107.016352","article-title":"Evaluation of the role of breast cancer resistance protein (BCRP\/ABCG2) and multidrug resistance-associated protein 4 (MRP4\/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-Methyl-1-phenyl-2-pyrazolin-5-one)","volume":"35","author":"Mizuno","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2013.09.002_bb0160","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1124\/dmd.111.041228","article-title":"Dose-dependent disposition of methotrexate in Abcc2 and Abcc3 gene knockout murine models","volume":"39","author":"Wang","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2013.09.002_bb0165","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2013.09.002_bb0170","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1038\/sj.onc.1206948","article-title":"P-glycoprotein: from genomics to mechanism","volume":"22","author":"Ambudkar","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.addr.2013.09.002_bb0175","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1360704","article-title":"Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line","volume":"258","author":"Cole","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.addr.2013.09.002_bb0180","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1080\/15216540701736285","article-title":"Role of the MRP1\/ABCC1 multidrug transporter protein in cancer","volume":"59","author":"Munoz","year":"2007","journal-title":"IUBMB Life"},{"key":"10.1016\/j.addr.2013.09.002_bb0185","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","article-title":"A multidrug resistance transporter from human MCF-7 breast cancer cells","volume":"95","author":"Doyle","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2013.09.002_bb0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10555-007-9042-6","article-title":"ABCG2: determining its relevance in clinical drug resistance","volume":"26","author":"Robey","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.addr.2013.09.002_bb0195","first-page":"95","article-title":"Cellular mechanisms of multidrug resistance of tumor cells","volume":"65","author":"Stavrovskaya","year":"2000","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.addr.2013.09.002_bb0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1124\/mol.63.1.65","article-title":"Breast cancer resistance protein (BCRP\/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors","volume":"63","author":"Wang","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.addr.2013.09.002_bb0205","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1124\/dmd.107.017723","article-title":"P-glycoprotein-mediated active efflux of the anti-HIV1 nucleoside abacavir limits cellular accumulation and brain distribution","volume":"35","author":"Shaik","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2013.09.002_bb0210","series-title":"Stem Cell Biology in Health and Disease","first-page":"385","article-title":"Potential molecular therapeutic targets in cancer stem\/progenitor cells: are ATP-binding cassette membrane transporters appropriate targets to eliminate cancer-initiating cells?","author":"Mimeault","year":"2010"},{"key":"10.1016\/j.addr.2013.09.002_bb0215","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2009.05.007","article-title":"Drug delivery systems in HIV pharmacotherapy: what has been done and the challenges standing ahead","volume":"138","author":"Sosnik","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2013.09.002_bb0220","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szakacs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2013.09.002_bb0225","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2174\/138945006777709520","article-title":"The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR)","volume":"7","author":"Teodori","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.addr.2013.09.002_bb0230","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1200\/JCO.2008.16.2123","article-title":"Reversal of drug resistance in ovarian cancer: where do we go from here?","volume":"26","author":"Kaye","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.addr.2013.09.002_bb0235","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1124\/jpet.107.127704","article-title":"Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells","volume":"324","author":"Shen","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2013.09.002_bb0240","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/0959-8049(96)00091-3","article-title":"Clinical trials of P-glycoprotein reversal in solid tumours","volume":"32A","author":"Ferry","year":"1996","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.addr.2013.09.002_bb0245","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1200\/JCO.2007.14.9807","article-title":"Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer","volume":"26","author":"L'homme","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.addr.2013.09.002_bb0250","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1158\/1078-0432.CCR-06-2414","article-title":"A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients","volume":"13","author":"Kuppens","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0255","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.bcp.2007.12.001","article-title":"Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R))","volume":"3","author":"Robey","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2013.09.002_bb0260","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1521-6926(04)00080-5","article-title":"Modulation of drug resistance transporters as a strategy for treating myelodysplastic syndrome","volume":"17","author":"Ross","year":"2004","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.addr.2013.09.002_bb0265","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00280-009-0925-9","article-title":"A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen","volume":"64","author":"Ruff","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.addr.2013.09.002_bb0270","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/S0959-8049(02)00490-2","article-title":"MDR1 inhibition: less resistance or less relevance?","volume":"38","author":"Garraway","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.addr.2013.09.002_bb0275","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1634\/theoncologist.8-5-411","article-title":"The role of ABC transporters in clinical practice","volume":"8","author":"Leonard","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.addr.2013.09.002_bb0280","first-page":"56","article-title":"Review of current issues in pharmaceutical excipients","volume":"31","author":"Chang","year":"2007","journal-title":"Pharm. Technol."},{"key":"10.1016\/j.addr.2013.09.002_bb0285","doi-asserted-by":"crossref","first-page":"112","DOI":"10.18773\/austprescr.2011.060","article-title":"Pharmaceutical excipients\u2014where do we begin?","volume":"34","author":"Haywood","year":"2011","journal-title":"Aust. Prescr."},{"key":"10.1016\/j.addr.2013.09.002_bb0290","series-title":"Encyclopedia of Pharmaceutical Technology","article-title":"Tablet formulation","author":"Augsburger","year":"2006"},{"key":"10.1016\/j.addr.2013.09.002_bb0295","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2004.03.001","article-title":"Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system","volume":"58","author":"Lindenberg","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2013.09.002_bb0300","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s11095-006-0284-8","article-title":"Nanotechnology: intelligent design to treat complex disease","volume":"23","author":"Couvreur","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0305","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2174\/1874764710801010043","article-title":"Polymeric nanocarriers: new endeavors for the optimization of the technological aspects of drugs","volume":"1","author":"Sosnik","year":"2008","journal-title":"Recent Pat. Biomed. Eng."},{"key":"10.1016\/j.addr.2013.09.002_bb0310","first-page":"82","article-title":"Poor aqueous solubility: an industry wide problem in drug discovery","volume":"5","author":"Lipinski","year":"2002","journal-title":"Am. Pharm. Rev."},{"key":"10.1016\/j.addr.2013.09.002_bb0315","first-page":"57","article-title":"Challenges & opportunities in oral delivery of poorly water-soluble drugs","volume":"6","author":"Giliyar","year":"2006","journal-title":"Drug Deliv. Technol."},{"key":"10.1016\/j.addr.2013.09.002_bb0320","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ejpb.2007.03.022","article-title":"Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs","volume":"66","author":"Chiappetta","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2013.09.002_bb0325","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2174\/138945011795906615","article-title":"PEO-PPO block copolymers for passive micellar targeting and overcoming multidrug resistance in cancer therapy","volume":"12","author":"Alvarez-Lorenzo","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.addr.2013.09.002_bb0330","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s11095-007-9347-8","article-title":"Natural and synthetic polymers as inhibitors of drug efflux pumps","volume":"25","author":"Werle","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0335","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0169-409X(02)00047-9","article-title":"Pluronic block copolymers for overcoming drug resistance in cancer","volume":"54","author":"Kabanov","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2013.09.002_bb0340","first-page":"98","article-title":"Pluronic Block Copolymers: Evolution of Drug Delivery Concept From Inert Nanocarriers to Biological Response Modifiers","volume":"130","author":"Batrakova","year":"2008"},{"key":"10.1016\/j.addr.2013.09.002_bb0345","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/sj.bjc.6601856","article-title":"Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer","volume":"90","author":"Danson","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.addr.2013.09.002_bb0350","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10637-010-9399-1","article-title":"A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction","volume":"29","author":"Valle","year":"2011","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.addr.2013.09.002_bb0360","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10863-007-9122-x","article-title":"ABCG transporters: structure, substrate specificities and physiological roles","volume":"39","author":"Velamakanni","year":"2007","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.addr.2013.09.002_bb0365","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/1479-7364-3-3-281","article-title":"Human ATP-binding cassette (ABC) transporter family","volume":"3","author":"Vasiliou","year":"2009","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.addr.2013.09.002_bb0370","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.tim.2007.09.005","article-title":"ABC transporters: how small machines do a big job","volume":"15","author":"Davidson","year":"2007","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.addr.2013.09.002_bb0375","first-page":"5232","article-title":"Evidence of multidrug resistant MRP functions as a co-transporter of glutathione and natural product toxins","volume":"57","author":"Rappa","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0380","first-page":"5130","article-title":"Characterization of vincristine transport by the Mr 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione","volume":"58","author":"Loe","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0385","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1432-1033.1997.00130.x","article-title":"Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities","volume":"250","author":"Shapiro","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.addr.2013.09.002_bb0390","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview","volume":"55","author":"Schinkel","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2013.09.002_bb0395","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1046\/j.1432-1327.1999.00098.x","article-title":"Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site","volume":"259","author":"Shapiro","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.addr.2013.09.002_bb0400","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1158\/1078-0432.CCR-09-0048","article-title":"Interaction of the multikinase inhibitors sorafenib and sunitinib with solute carriers and ATP-binding cassette transporters","volume":"15","author":"Hu","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0405","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ijc.21827","article-title":"In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging technique","volume":"119","author":"Jekerle","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.addr.2013.09.002_bb0410","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.bcp.2011.07.081","article-title":"Efavirenz is a substrate and in turn modulates the expression of the efflux transporter ABCG2\/BCRP in the gastrointestinal tract of the rat","volume":"82","author":"Peroni","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2013.09.002_bb0415","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.vascn.2012.02.002","article-title":"Determining P-glycoprotein\u2013drug interactions: evaluation of reconstituted P-glycoprotein in a liposomal system and LLC-MDR1 polarized cell monolayers","volume":"65","author":"Melchior","year":"2012","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.addr.2013.09.002_bb0420","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/00002030-200107270-00004","article-title":"P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance?","volume":"15","author":"Jones","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.addr.2013.09.002_bb0425","first-page":"310","article-title":"Influence of P-Glycoprotein on the transport and metabolism of indinavir in Caco-2 cells expressing cytochrome P-450 3A4","volume":"292","author":"Hochman","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2013.09.002_bb0430","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1097\/QAD.0b013e328332c3a5","article-title":"How much ritonavir is needed to boost protease inhibitors? Systematic review of 17 dose-ranging pharmacokinetic trials","volume":"23","author":"Hill","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.addr.2013.09.002_bb0435","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/138920111795164020","article-title":"Transporters in the CNS\u2014an inventory","volume":"12","author":"Hartz","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.addr.2013.09.002_bb0440","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1038\/tp.2012.115","article-title":"ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression","volume":"2","author":"Singh","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.addr.2013.09.002_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(96)01478-0","article-title":"Membrane topology distinguishes a subfamily of the ATP-binding cassette (ABC) transporters","volume":"402","author":"Tusnady","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.addr.2013.09.002_bb0450","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2217\/14622416.9.1.105","article-title":"ABC multidrug transporters: structure, function and role in chemoresistance","volume":"9","author":"Sharom","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.addr.2013.09.002_bb0455","first-page":"5902","article-title":"Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells","volume":"54","author":"Cole","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0460","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI119886","article-title":"Drug export activity of the human canalicular multispecific organic anion transporter in polar kidney MDCK cells expressing cMOAT (MRP2) cDNA","volume":"101","author":"Evers","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2013.09.002_bb0465","doi-asserted-by":"crossref","first-page":"23538","DOI":"10.1074\/jbc.M303504200","article-title":"Evidence for two interacting ligand-binding sites in human MRP2 (ABCC2)","volume":"278","author":"Zelcer","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2013.09.002_bb0470","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1054\/bjoc.2000.1262","article-title":"Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export","volume":"83","author":"Evers","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.addr.2013.09.002_bb0475","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1101\/gr.GR-1649R","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"11","author":"Dean","year":"2001","journal-title":"Genome Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0480","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1042\/BJ20040791","article-title":"Arginine-482 is not essential for transport of antibiotics, primary bile acids and unconjugated sterols by the human breast cancer resistance protein (ABCG2)","volume":"385","author":"Janvilisri","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.addr.2013.09.002_bb0485","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/ijc.10100","article-title":"Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization","volume":"97","author":"Kage","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.addr.2013.09.002_bb0490","first-page":"5337","article-title":"A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance","volume":"58","author":"Allikmets","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0495","first-page":"935","article-title":"Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918","volume":"7","author":"Maliepaard","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0500","first-page":"3458","article-title":"Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues","volume":"61","author":"Maliepaard","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0505","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/00001756-200211150-00014","article-title":"Localisation of breast cancer resistance protein in microvessel endothelium of human brain","volume":"13","author":"Cooray","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.addr.2013.09.002_bb0510","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.lfs.2010.02.012","article-title":"ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy","volume":"86","author":"Ding","year":"2010","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2013.09.002_bb0515","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drup.2012.03.002","article-title":"Collateral sensitivity as a strategy against cancer multidrug resistance","volume":"15","author":"Pluchino","year":"2012","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.addr.2013.09.002_bb0520","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00432-004-0653-9","article-title":"Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications","volume":"131","author":"Berger","year":"2005","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.addr.2013.09.002_bb0525","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2174\/138920111795163913","article-title":"The challenge of exploiting ABCG2 in the clinic","volume":"12","author":"Robey","year":"2010","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.addr.2013.09.002_bb0530","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1158\/1078-0432.CCR-10-1725","article-title":"A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer","volume":"17","author":"Kelly","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0535","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1042\/bse0500209","article-title":"The controversial role of ABC transporters in clinical oncology","volume":"50","author":"Tamaki","year":"2011","journal-title":"Essays Biochem."},{"key":"10.1016\/j.addr.2013.09.002_bb0540","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/med.20239","article-title":"Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression","volume":"32","author":"Nobili","year":"2012","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.addr.2013.09.002_bb0545","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2174\/092986706777585077","article-title":"Multidrug resistance: retrospect and prospects in anti-cancer drug treatment","volume":"13","author":"Perez-Tomas","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.addr.2013.09.002_bb0550","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1016\/S0024-3205(02)02175-6","article-title":"Toxicologic and pharmacokinetic study of low doses of verapamil combined with doxorubicin","volume":"71","author":"Candussio","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2013.09.002_bb0555","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1021\/jm049065t","article-title":"Transmembrane inhibitors of P-glycoprotein, an ABC Transporter","volume":"48","author":"Tarasova","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2013.09.002_bb0560","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2174\/138945006777709520","article-title":"The functions and structure of ABC transporters: implications for the design of new inhibitors of P-gp and MRP1 to control multidrug resistance (MDR)","volume":"7","author":"Teodori","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.addr.2013.09.002_bb0565","doi-asserted-by":"crossref","first-page":"6924","DOI":"10.1073\/pnas.95.12.6924","article-title":"A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels","volume":"95","author":"Randolph","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2013.09.002_bb0570","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0092-8674(00)00179-3","article-title":"The leukotriene C4 transporter MRP1 regulates CCL19 (MIP-3\u03b2, ELC)-dependent mobilization of dendritic cells to lymph nodes","volume":"103","author":"Robbiani","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.addr.2013.09.002_bb0575","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1182\/blood-2008-03-147850","article-title":"A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migration","volume":"112","author":"van de Ven","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.addr.2013.09.002_bb0580","first-page":"1195","article-title":"Potentiation of drug effect by Tween 80 in Chinese hamster cells resistant to actinomycin D and daunomycin","volume":"32","author":"Riehm","year":"1972","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0585","first-page":"4199","article-title":"Reversal of the multidrug resistance phenotype with Cremophor EL, a common vehicle for water-insoluble vitamins and drugs","volume":"50","author":"Woodcock","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0590","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/bjc.1990.335","article-title":"The polyoxyethylene castor oil Cremophor EL modifies multidrug resistance","volume":"62","author":"Schuurhuis","year":"1990","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.addr.2013.09.002_bb0595","first-page":"297","article-title":"The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor","volume":"2","author":"Friche","year":"1990","journal-title":"Cancer Commun."},{"key":"10.1016\/j.addr.2013.09.002_bb0600","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0006-2952(91)90531-9","article-title":"P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines. Evidence for a saturation of active daunorubicin transport","volume":"41","author":"Spoelstra","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2013.09.002_bb0605","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/bjc.1992.217","article-title":"Reversal of multidrug resistance by surfactants","volume":"66","author":"Woodcock","year":"1992","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.addr.2013.09.002_bb0610","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1182\/blood.V83.5.1337.1337","article-title":"Synergistic reversal of multidrug-resistance phenotype in acute myeloid leukaemia cells by cyclosporin A and Cremophor EL","volume":"83","author":"Ross","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.addr.2013.09.002_bb0615","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1021\/bc950093n","article-title":"Hypersensitization of multidrug resistant human ovarian carcinoma cells by Pluronic P85 block copolymer","volume":"7","author":"Alakhov","year":"1996","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2013.09.002_bb0620","first-page":"3626","article-title":"Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells","volume":"56","author":"Venne","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0625","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.addr.2009.11.023","article-title":"New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery","volume":"62","author":"Sosnik","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2013.09.002_bb0630","unstructured":"B. Carreno-Gomez, R. Duncan, Compositions with enhanced oral bioavailability, U.S. Patent application #20030211072 (2002)."},{"key":"10.1016\/j.addr.2013.09.002_bb0635","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1021\/bc00032a002","article-title":"Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates","volume":"6","author":"Zalipsky","year":"1995","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2013.09.002_bb0640","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1002\/anie.200902672","article-title":"Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives","volume":"49","author":"Knop","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2013.09.002_bb0645","series-title":"Poly(ethylene Glycol): Chemistry and Biological Applications","first-page":"1","article-title":"Introduction to biotechnical and biomedical applications of poly(ethylene glycol)","volume":"680","author":"Harris","year":"1997"},{"key":"10.1016\/j.addr.2013.09.002_bb0650","doi-asserted-by":"crossref","first-page":"E40","DOI":"10.1208\/ps040440","article-title":"An in vitro examination of the impact of polyehtylene glycol 400, pluronic P 85 and vitamin E D-a-tocopheryl polyethylene glycol 1000 succinate on p-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine","volume":"4","author":"Johnson","year":"2002","journal-title":"AAPS PharmSci"},{"key":"10.1016\/j.addr.2013.09.002_bb0655","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2006.01.020","article-title":"Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies","volume":"313","author":"Shen","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2013.09.002_bb0660","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/jps.10175","article-title":"Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers","volume":"91","author":"Hugger","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2013.09.002_bb0665","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/jps.10176","article-title":"A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro","volume":"91","author":"Hugger","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2013.09.002_bb0670","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1211\/jpp.60.12.0009","article-title":"Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies","volume":"60","author":"Shen","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2013.09.002_bb0675","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpharm.2004.05.014","article-title":"Enhanced paclitaxel bioavailability after oral administration of pegylated paclitaxel prodrug for oral delivery in rats","volume":"280","author":"Choi","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2013.09.002_bb0680","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jps.10265","article-title":"Automated analysis of polyethylene glycol-induced inhibition of P-glycoprotein activity in vitro","volume":"92","author":"Hugger","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2013.09.002_bb0685","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/jps.20017","article-title":"Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes","volume":"93","author":"Shono","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2013.09.002_bb0690","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0168-3659(03)00163-9","article-title":"Relationships between the hydrophilic\u2013lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines","volume":"90","author":"Lo","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2013.09.002_bb0695","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/BF02976689","article-title":"Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats","volume":"26","author":"Zhang","year":"2003","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0700","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0928-0987(02)00055-6","article-title":"Effects of non-ionic surfactants on membrane transporters in Caco-2 cell monolayers","volume":"16","author":"Rege","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2013.09.002_bb0705","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1023\/A:1016033702220","article-title":"The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system","volume":"13","author":"Nerurkar","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0710","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejps.2005.04.003","article-title":"Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo","volume":"25","author":"Varma","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2013.09.002_bb0715","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2005.11.005","article-title":"Influence of vitamin E TPGS poly(ethlyene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers","volume":"111","author":"Collnot","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2013.09.002_bb0720","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.1016\/j.biomaterials.2006.08.004","article-title":"In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein","volume":"27","author":"Foger","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2013.09.002_bb0725","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/jbm.a.31402","article-title":"Potential use of cholecalciferol polyethylene glycol succinate as a novel pharmaceutical additive","volume":"84","author":"Zhao","year":"2008","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.addr.2013.09.002_bb0730","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1248\/bpb.30.1301","article-title":"Effects of labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats","volume":"30","author":"Lin","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.addr.2013.09.002_bb0735","first-page":"319","article-title":"Lipid excipients Peceol and Gelucire 44\/14 decrease P-glycoprotein-mediated efflux of Rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells","volume":"10","author":"Sachs-Barrable","year":"2007","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.addr.2013.09.002_bb0740","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.addr.2007.08.042","article-title":"Enhancing drug absorption using lipids: a case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infections","volume":"60","author":"Sachs-Barrable","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2013.09.002_bb0745","first-page":"115","article-title":"Temperature- and pH-sensitive polymeric micelles for drug encapsulation, release and targeting","volume":"vol. 1","author":"Sosnik","year":"2013"},{"key":"10.1016\/j.addr.2013.09.002_bb0750","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1022080115804","article-title":"Novel reverse thermo-responsive injectable poly(ether carbonate)s","volume":"14","author":"Cohn","year":"2003","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.addr.2013.09.002_bb0755","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1163\/156856203763572680","article-title":"Crosslinkable PEO-PPO-PEO-based reverse thermo-responsive gels as potentially injectable materials","volume":"14","author":"Sosnik","year":"2003","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.addr.2013.09.002_bb0760","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1016\/j.biomaterials.2003.09.057","article-title":"Ethoxysilane-capped PEO-PPO-PEO triblocks: a new family of reverse thermo-responsive polymers","volume":"25","author":"Sosnik","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2013.09.002_bb0765","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biomaterials.2004.02.041","article-title":"Reverse thermo-responsive poly(ethylene oxide) and poly(propylene oxide) multiblock copolymers","volume":"26","author":"Sosnik","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2013.09.002_bb0770","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1021\/bm0495250","article-title":"Smart hydrogels for in situ-generated implants","volume":"6","author":"Cohn","year":"2005","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2013.09.002_bb0775","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.1016\/j.biomaterials.2005.05.086","article-title":"Semi-synthetic collagen\/poloxamine matrices for Tissue Engineering","volume":"26","author":"Sosnik","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2013.09.002_bb0780","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1089\/ten.2005.11.1807","article-title":"Collagen\/poloxamine hydrogels: cytocompatibility of embedded HepG2 cells and surface attached endothelial cells","volume":"11","author":"Sosnik","year":"2005","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.addr.2013.09.002_bb0785","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/jbm.a.30419","article-title":"Poloxamine hydrogels with a quaternary ammonium modification to improve cell attachment","volume":"75","author":"Sosnik","year":"2005","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.addr.2013.09.002_bb0790","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1021\/bm050693h","article-title":"Methylation of poloxamine for enhanced cell adhesion","volume":"7","author":"Sosnik","year":"2006","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2013.09.002_bb0795","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.biomaterials.2005.10.035","article-title":"Novel degradable reverse thermoresponsive multiblock copolymers","volume":"27","author":"Cohn","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2013.09.002_bb0800","series-title":"Hydrogels: Biological properties and applications","first-page":"79","article-title":"Poloxamine hydrogels: from non-cell adhesive substrates to matrices with improved cytocompatibility for Tissue Engineering applications","author":"Sosnik","year":"2009"},{"key":"10.1016\/j.addr.2013.09.002_bb0805","series-title":"Handbook of Biodegradable Polymers","first-page":"231","article-title":"The poloxamers: their chemistry and medical applications","volume":"vol. 7","author":"Reeve","year":"1997"},{"key":"10.1016\/j.addr.2013.09.002_bb0810","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/157488810790442831","article-title":"Repair of bone defect using bone marrow cells and demineralized bone matrix supplemented with polymeric materials","volume":"5","author":"Kurkalli","year":"2010","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.addr.2013.09.002_bb0815","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1098\/rsif.2012.0102","article-title":"Single and mixed poloxamine micelles as suitable nanocarriers for solubilization and sustained release of ethoxzolamide for topical glaucoma therapy","volume":"9","author":"Ribeiro","year":"2012","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.addr.2013.09.002_bb0820","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0169-409X(97)00121-X","article-title":"Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery","volume":"31","author":"Bromberg","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2013.09.002_bb0825","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s11095-006-9104-4","article-title":"A review of poloxamer 407 pharmaceutical and pharmacological characteristics","volume":"23","author":"Dumortier","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0830","series-title":"Handbook of Pharmaceutical Excipients","first-page":"386","author":"Kibbe","year":"2000"},{"key":"10.1016\/j.addr.2013.09.002_bb0835","first-page":"91","article-title":"Solubilisation of polyaromatic hydrocarbons in aqueous solution of poloxamine T803","volume":"212","author":"Dong","year":"2003","journal-title":"Colloids Surf. A: Physicochem. Eng. Aspects"},{"key":"10.1016\/j.addr.2013.09.002_bb0840","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ejpb.2006.10.010","article-title":"Tetronic micellization, gelation and drug solubilization: influence of pH and ionic strength","volume":"66","author":"Alvarez-Lorenzo","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2013.09.002_bb0845","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10973-006-7834-5","article-title":"Calorimetric approach to tetronic\/water interactions","volume":"87","author":"Fernandez-Tarrio","year":"2007","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.addr.2013.09.002_bb0850","doi-asserted-by":"crossref","first-page":"10688","DOI":"10.1021\/la8016563","article-title":"Self-associative behavior and drug solubilizing ability of poloxamine (Tetronic\u00ae) block copolymers","volume":"24","author":"Gonzalez-Lopez","year":"2008","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2013.09.002_bb0855","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejpb.2010.05.007","article-title":"N-alkylation of poloxamines modulates micellar encapsulation and release of the antiretroviral efavirenz","volume":"76","author":"Chiappetta","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2013.09.002_bb0860","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1021\/ma00087a009","article-title":"Micellization of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymers in aqueous solutions: thermodynamics of copolymer association","volume":"27","author":"Alexandridis","year":"1994","journal-title":"Macromolecules"},{"key":"10.1016\/j.addr.2013.09.002_bb0865","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0169-409X(02)00047-9","article-title":"Pluronic\u00ae block copolymers for overcoming drug resistance in cancer","volume":"54","author":"Kabanov","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2013.09.002_bb0870","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/bjc.1996.587","article-title":"Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity","volume":"74","author":"Batrakova","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.addr.2013.09.002_bb0875","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1021\/bc970118d","article-title":"Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption","volume":"8","author":"Miller","year":"1997","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2013.09.002_bb0880","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1023\/A:1011964213024","article-title":"Effects of Pluronic block copolymers on drug absorption in Caco-2 cell monolayers","volume":"15","author":"Batrakova","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0885","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1023\/A:1011942814300","article-title":"Effects of Pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells","volume":"15","author":"Batrakova","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0890","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1023\/A:1018990706838","article-title":"Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers","volume":"16","author":"Batrakova","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0895","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1023\/A:1018873702411","article-title":"Inhibition of multidrug resistance-associated protein (MRP): functional activity with Pluronic block copolymers","volume":"16","author":"Miller","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0900","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1023\/A:1018942823676","article-title":"Fundamental relationships between the composition of Pluronic block copolymers and their hypersensitization effect in MDR cancer cells","volume":"16","author":"Batrakova","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0905","first-page":"551","article-title":"Pluronic P85 enhances the delivery of digoxin to the brain: In vitro and in vivo studies","volume":"296","author":"Batrakova","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2013.09.002_bb0910","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0927-7765(99)00064-8","article-title":"Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials","volume":"16","author":"Alakhov","year":"1999","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.addr.2013.09.002_bb0915","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1023\/A:1026179132599","article-title":"Sensitization of cells overexpressing multidrug-resistant proteins by Pluronic P85","volume":"20","author":"Batrakova","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0920","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jconrel.2010.01.004","article-title":"Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancer","volume":"143","author":"Batrakova","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2013.09.002_bb0925","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1021\/bm034134r","article-title":"Small-angle X-ray scattering study of the interaction of poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) triblock copolymers with lipid bilayers","volume":"4","author":"Firestone","year":"2003","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2013.09.002_bb0930","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1021\/bm701348r","article-title":"Electron density mapping of triblock copolymers associated with model biomembranes: insights into conformational states and effect on bilayer structure","volume":"9","author":"Lee","year":"2008","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2013.09.002_bb0935","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0014-5793(99)00208-2","article-title":"Interaction of tumor and normal blood cells ethylene oxide and propylene oxide block copolymers","volume":"446","author":"Melik-Nubarov","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.addr.2013.09.002_bb0940","first-page":"483","article-title":"Mechanism of Pluronic effect on P-Glycoprotein efflux system in blood\u2013brain barrier: contributions of energy depletion and membrane fluidization","volume":"299","author":"Batrakova","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2013.09.002_bb0945","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1054\/bjoc.2001.2165","article-title":"Mechanism of sensitization of MDR by Pluronic block copolymers: selective energy depletion","volume":"85","author":"Batrakova","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.addr.2013.09.002_bb0950","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1470-8744.1993.tb00276.x","article-title":"The influence of pluronics and their conjugates with proteins on the rate of oxygen consumption by liver mitochondria and thymus lymphocytes","volume":"18","author":"Kirillova","year":"1993","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.addr.2013.09.002_bb0955","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/abbi.2000.2104","article-title":"Effect of a polymeric surfactant on electron transport in HL-60 cells","volume":"384","author":"Rapoport","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.addr.2013.09.002_bb0960","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejpb.2012.09.014","article-title":"Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123\/F127 block copolymers: relationship between copolymer concentration and inhibitory activity","volume":"83","author":"Wei","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2013.09.002_bb0965","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0168-3659(03)00211-6","article-title":"An essential relationship between ATP depletion and chemosensitizing activity of Pluronic\u00ae block copolymers","volume":"91","author":"Kabanov","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2013.09.002_bb0970","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2009.09.026","article-title":"Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers","volume":"142","author":"Alakhova","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2013.09.002_bb0975","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/bi035768l","article-title":"Ionophoric activity of Pluronic block copolymers","volume":"43","author":"Krylova","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2013.09.002_bb0980","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1007\/s11095-004-7675-5","article-title":"Effect of Pluronic P85 on ATPase activity of drug efflux transporters","volume":"21","author":"Batrakova","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2013.09.002_bb0985","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jconrel.2005.03.019","article-title":"Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells","volume":"105","author":"Minko","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2013.09.002_bb0990","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1016\/j.bmcl.2012.09.012","article-title":"Downregulation of mdr1 and abcg2 genes is a mechanism of inhibition of efflux pumps mediated by polymeric amphiphiles","volume":"22","author":"Cuestas","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.addr.2013.09.002_bb0995","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2008.07.031","article-title":"Prevention of MDR development in leukaemia cells by micelle-forming polymeric surfactant","volume":"131","author":"Sharma","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2013.09.002_bb1000","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc1566","article-title":"Cancer nanotechnology: opportunities and challenges","volume":"5","author":"Ferrari","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.addr.2013.09.002_bb1010","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2217\/nnm.10.53","article-title":"Inhibition of P-glycoprotein pumps by PEO-PPO amphiphiles: branched versus linear derivatives","volume":"5","author":"Alvarez-Lorenzo","year":"2010","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.addr.2013.09.002_bb1015","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/sj.jcbfm.9600414","article-title":"Novel delivery system enhances efficacy of antiretroviral therapy in animal model for HIV-1 encephalitis","volume":"27","author":"Spitzenberger","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.addr.2013.09.002_bb1020","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1002\/jps.21372","article-title":"Interactions of Pluronic block copolymers on P-gp efflux activity: experience with HIV-1 protease inhibitors","volume":"97","author":"Shaik","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2013.09.002_bb1025","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1002\/jps.21723","article-title":"Investigation of the micellar effect of Pluronic P85 on P-glycoprotein inhibition: cell accumulation and equilibrium dialysis studies","volume":"98","author":"Shaik","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2013.09.002_bb1030","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1021\/mp2000132","article-title":"Poloxamines display a multiple inhibitory activity of ATP-Binding Cassette (ABC) transporters in cancer cell lines","volume":"8","author":"Cuestas","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2013.09.002_bb1035","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.addr.2009.11.010","article-title":"Nanotechnology solutions for infectious diseases in developing nations","volume":"62","author":"Sosnik","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2013.09.002_bb1040","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2217\/nnm.10.64","article-title":"Nanotechnology contributions to the pharmacotherapy of pediatric HIV: a dual scientific and ethical challenge and a still pending agenda","volume":"5","author":"Sosnik","year":"2010","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.addr.2013.09.002_bb1045","first-page":"83","article-title":"Evaluation of the use of partition coefficients and molecular surface properties as predictors of drug absorption: a provisional biopharmaceutical classification of the list of national essential medicines of Pakistan","volume":"19","author":"Rahman","year":"2011","journal-title":"DARU"},{"key":"10.1016\/j.addr.2013.09.002_bb1050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","article-title":"Predicting drug disposition via application of BCS: transport\/absorption\/elimination interplay and development of biopharmaceutics drug disposition classification system","volume":"22","author":"Wu","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2013.09.002_bb1055","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1124\/dmd.108.020974","article-title":"Investigation of the role of breast cancer resistance protein (Bcrp\/Abcg2) on pharmacokinetics and central nervous system penetration of abacavir and zidovudine in the mouse","volume":"36","author":"Giri","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2013.09.002_bb1060","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s11095-005-5271-y","article-title":"Quantitative assessment of HIV-1 protease inhibitor interactions with drug efflux transporters in the blood\u2013brain barrier","volume":"22","author":"Bachmeier","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2013.09.002_bb1065","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1128\/AAC.46.11.3456-3462.2002","article-title":"Direct evidence that saquinavir is transported by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2)","volume":"46","author":"Williams","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2013.09.002_bb1070","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.addr.2009.11.020","article-title":"Nanotechnology applications for improved delivery of antiretroviral drugs to the brain","volume":"62","author":"Wong","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2013.09.002_bb1075","series-title":"First World Conference on Nanomedicine and Drug Delivery (WCN-2010), Kottakam, India","article-title":"The anti-HIV drug EFAVIRENZ is substrate and modulates the expression of the efflux transporter BCRP (ABCG2) in rats","author":"Peroni","year":"2010"},{"key":"10.1016\/j.addr.2013.09.002_bb1080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2217\/nnm.09.90","article-title":"Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability","volume":"5","author":"Chiappetta","year":"2010","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.addr.2013.09.002_bb1085","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.biomaterials.2010.11.082","article-title":"Oral pharmacokinetics of efavirenz-loaded polymeric micelles","volume":"32","author":"Chiappetta","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2013.09.002_bb1090","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nano.2011.01.017","article-title":"Synergistic encapsulation of the anti-HIV agent efavirenz within poly(ethylene oxide)-poly(propylene oxide) mixed polymeric micelles","volume":"7","author":"Chiappetta","year":"2011","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.addr.2013.09.002_bb1095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2217\/nnm.12.104","article-title":"Intranasal administration of antiretroviral-loaded micelles for anatomical targeting to the brain in HIV","volume":"8","author":"Chiappetta","year":"2013","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.addr.2013.09.002_bb1100","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/1521-3927(20000601)21:9<501::AID-MARC501>3.0.CO;2-R","article-title":"Effects of block architecture and composition on the association properties of poly(oxyalkylene) copolymers in aqueous solution","volume":"21","author":"Booth","year":"2000","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.addr.2013.09.002_bb1105","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1039\/b605367j","article-title":"Self-association of block copoly(oxyalkylene)s in aqueous solution. Effects of composition, block length and block architecture","volume":"8","author":"Booth","year":"2006","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"1","key":"10.1016\/j.addr.2013.09.002_bb1110","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2013.01.010","article-title":"Poly(styrene oxide)-poly(ethylene oxide) block copolymers: from \u201cclassical\u201d chemotherapeutic nanocarriers to active cell-response inducers","volume":"167","author":"Camb\u00f3n","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.addr.2013.09.002_bb1115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0378-5173(95)04386-1","article-title":"Development of amphiphilic diblock copolymers as micellar carriers of taxol","volume":"132","author":"Zhang","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2013.09.002_bb1120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s002800050630","article-title":"An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel","volume":"40","author":"Zhang","year":"1997","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.addr.2013.09.002_bb1125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0927-7765(99)00067-3","article-title":"Development of copolymers of poly(d, l-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel","volume":"16","author":"Burt","year":"1999","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.addr.2013.09.002_bb1130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0169-409X(02)00016-9","article-title":"Polyether-ester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formations","volume":"54","author":"Liggins","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2013.09.002_bb1135","first-page":"3708","article-title":"Clinical Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies","volume":"10","author":"Kim","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2013.09.002_bb1140","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jconrel.2005.12.024","article-title":"Novel drug release profiles from micellar solutions of PLA-PEO-PLA triblock copolymers","volume":"112","author":"Agrawal","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2013.09.002_bb1145","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1002\/pola.24255","article-title":"Synthesis, self-assembly, drug-release behavior, and cytotoxicity of triblock and pentablock copolymers composed of poly(\u03b5-caprolactone), poly(l-lactide), and poly(ethylene glycol)","volume":"48","author":"Sun","year":"2010","journal-title":"J. Polym. Sci. Part A: Polym Chem."},{"key":"10.1016\/j.addr.2013.09.002_bb1150","doi-asserted-by":"crossref","first-page":"12890","DOI":"10.1021\/la101613b","article-title":"Self-aggregation of gel forming PEG-PLA star block copolymers in water","volume":"26","author":"Calucci","year":"2010","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2013.09.002_bb1155","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1023\/B:PHAM.0000036925.45002.a2","article-title":"Evidence for modulation of P-glycoprotein-mediated efflux by methoxypolyethylene glycol-block-polycaprolactone amphiphilic diblock copolymers","volume":"21","author":"Zastre","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2013.09.002_bb1160","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/jps.20785","article-title":"Methoxypolyethylene glycol-block-polycaprolactone diblock copolymers reduce P-glycoprotein efflux in the absence of a membrane fluidization effect while stimulating P-glycoprotein ATPase activity","volume":"96","author":"Zastre","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2013.09.002_bb1165","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1016\/j.biomaterials.2012.03.013","article-title":"Poly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumors","volume":"33","author":"Wang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2013.09.002_bb1170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0168-3659(02)00419-4","article-title":"Effects of polyether-modified poly(acrylic acid) microgels on doxorubicin transport in human intestinal epithelial Caco-2 cell layers","volume":"88","author":"Bromberg","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2013.09.002_bb1175","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/802693","article-title":"Chitosan and chitosan derivatives for biological applications: chemistry and functionalization","author":"Sarmento","year":"2011","journal-title":"Int. J. Carbohydr. Chem."},{"key":"10.1016\/j.addr.2013.09.002_bb1180","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/865704","article-title":"Chitosan-grafted copolymers and chitosan\u2013ligand conjugates as matrices for pulmonary drug delivery","author":"Andrade","year":"2011","journal-title":"Int. J. Carbohydr. Chem."},{"key":"10.1016\/j.addr.2013.09.002_bb1185","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2005.11.011","article-title":"Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine","volume":"111","author":"Werle","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2013.09.002_bb1190","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1016\/j.biomaterials.2006.03.033","article-title":"In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan","volume":"27","author":"Foger","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2013.09.002_bb1195","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/10611860601140798","article-title":"Enhanced transport of P-glycoprotein substrate saquinavir in presence of thiolated chitosan","volume":"15","author":"Foger","year":"2006","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2013.09.002_bb1200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/10611860701850130","article-title":"Effect of a thiolated polymer on oral paclitaxel absorption and tumor growth in rats","volume":"16","author":"F\u00f6ger","year":"2008","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2013.09.002_bb1205","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ejpb.2009.03.008","article-title":"In vivo evaluation of thiolated poly(acrylic acid) as a drug absorption modulator for MRP2 efflux pump substrates","volume":"72","author":"Greindl","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2013.09.002_bb1210","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1773-2247(09)50084-6","article-title":"The efflux pump inhibitory properties of (thiolated) polyallylamines","volume":"19","author":"Vigl","year":"2009","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.addr.2013.09.002_bb1215","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2010.06.023","article-title":"Design and in vitro evaluation of a novel polymeric P-glycoprotein (P-gp) inhibitor","volume":"147","author":"Iqbal","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2013.09.002_bb1220","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejpb.2010.08.008","article-title":"Thiolated hydroxyethylcellulose: synthesis and in vitro evaluation","volume":"76","author":"Sarti","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2013.09.002_bb1225","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3109\/03639045.2010.534484","article-title":"Thiolated chitosans: influence of various sulfhydryl ligands on permeation-enhancing and P-gp inhibitory properties","volume":"37","author":"Sakloetsakun","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2013.09.002_bb1230","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1021\/mp200598j","article-title":"S-Protected thiolated chitosan for oral delivery of hydrophilic macromolecules: evaluation of permeation enhancing and efflux pump inhibitory properties","volume":"9","author":"D\u00fcnnhaupt","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2013.09.002_bb1235","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jconrel.2012.12.001","article-title":"Thiomer-coated liposomes harbor permeation enhancing and efflux pump inhibitory properties","volume":"165","author":"Gradauer","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2013.09.002_bb1240","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jconrel.2003.12.006","article-title":"The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability","volume":"95","author":"Emanuele","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2013.09.002_bb1245","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1021\/bc060325q","article-title":"Synthesis and assessment of first-generation polyamidoamine dendrimer prodrugs to enhance the cellular permeability of P-gp substrates","volume":"18","author":"Najlah","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2013.09.002_bb1250","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","article-title":"Cyclodextrins as pharmaceutical solubilizers","volume":"59","author":"Brewster","year":"2007","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.addr.2013.09.002_bb1255","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.bbamem.2007.03.026","article-title":"Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies","volume":"1768","author":"Zidovetzki","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2013.09.002_bb1260","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1016\/j.bbamem.2007.06.026","article-title":"Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporter","volume":"1768","author":"Telbisz","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2013.09.002_bb1265","doi-asserted-by":"crossref","first-page":"12097","DOI":"10.1073\/pnas.200367697","article-title":"Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR\u03b1","volume":"97","author":"Venkateswaran","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2013.09.002_bb1270","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1097-2765(01)00164-2","article-title":"A PPAR\u03b3-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis","volume":"7","author":"Chawia","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.addr.2013.09.002_bb1275","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1248\/cpb.36.2176","article-title":"Some properties and the inclusion behavior of branched cyclodextrins","volume":"36","author":"Okada","year":"1988","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.addr.2013.09.002_bb1280","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.carres.2011.02.023","article-title":"Physicochemical and biological properties of 2-O-\u03b1-d-galactosyl-cyclomaltohexaose (\u03b1-cyclodextrin) and -cyclomaltoheptaose (\u03b2-cyclodextrin)","volume":"346","author":"Okada","year":"2011","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.addr.2013.09.002_bb1285","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.carres.2012.04.019","article-title":"Effect of 6-O-a-maltosyl-b cyclodextrin and its cholesterol inclusion complex on cellular cholesterol levels and ABCA1 and ABCG1 expression in mouse mastocytoma P-815 cells","volume":"357","author":"Okada","year":"2012","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.addr.2013.09.002_bb1290","doi-asserted-by":"crossref","first-page":"13686","DOI":"10.1021\/bi801409r","article-title":"Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport","volume":"47","author":"Eckford","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2013.09.002_bb1295","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1023\/B:PHAM.0000022409.27896.d4","article-title":"Contribution of cholesterol and phospholipids to inhibitory effect of dimethyl-\u03b2-cyclodextrin on efflux function of P-glycoprotein and multidrug resistance-associated protein 2 in vinblastine-resistant Caco-2 cell monolayers","volume":"21","author":"Arima","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2013.09.002_bb1300","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejps.2008.04.005","article-title":"P-glycoprotein inhibition by membrane cholesterol modulation","volume":"34","author":"Fenyvesi","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2013.09.002_bb1305","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00424-006-0047-8","article-title":"The ABCA subfamily\u2014gene and protein structures, functions and associated hereditary diseases","volume":"453","author":"Albrecht","year":"2007","journal-title":"Pflugers Arch. Eur. J. Physiol."},{"key":"10.1016\/j.addr.2013.09.002_bb1310","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1158\/1078-0432.CCR-05-2587","article-title":"ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukaemia","volume":"12","author":"Steinbach","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2013.09.002_bb1315","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.biochem.71.102301.093055","article-title":"Mammalian ABC transporters in health and disease","volume":"71","author":"Borst","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.addr.2013.09.002_bb1320","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/bbrc.2001.5326","article-title":"ABCA6, a novel a class of ABC transporter","volume":"285","author":"Kaminski","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2013.09.002_bb1325","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1158\/0008-5472.CAN-04-3327","article-title":"ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma","volume":"65","author":"Frank","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2013.09.002_bb1330","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1152\/physiol.00046.2006","article-title":"Structure and function of ABC transporters","volume":"22","author":"Linton","year":"2007","journal-title":"Physiology"},{"key":"10.1016\/j.addr.2013.09.002_bb1335","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-11-0221","article-title":"ABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patients","volume":"71","author":"Wilson","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2013.09.002_bb1340","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1111\/j.1742-4658.2011.08235.x","article-title":"Multidrug resistance proteins (MRPs\/ABCCs) in cancer chemotherapy and genetic diseases","volume":"278","author":"Chen","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.addr.2013.09.002_bb1345","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.bbadis.2006.01.011","article-title":"ABC A-subfamily transporters: structure, function and disease","volume":"1762","author":"Kaminski","year":"2006","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Basis Dis."},{"key":"10.1016\/j.addr.2013.09.002_bb1350","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.coph.2006.01.009","article-title":"Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer","volume":"6","author":"Modok","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.addr.2013.09.002_bb1355","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1172\/JCI45023","article-title":"Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice","volume":"121","author":"Hara","year":"2011","journal-title":"J. Clin. Invest."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X1300197X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X1300197X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:57:39Z","timestamp":1715986659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X1300197X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":269,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0169409X1300197X"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2013.09.002","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing \u201cGenerally Recognized As Safe\u201d (GRAS) nanopharmaceuticals: A review","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2013.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}